Open-label, dose-escalation, and expansion trial of CA-4948 in combination with ibrutinib in patients with relapsed or refractory hematologic malignancies Meeting Abstract
| Authors: | Joffe, E.; Nowakowski, G. S.; Tun, H. W.; Rosenthal, A. C.; Lunning, M. A.; Ramchandren, R.; Li, C. C.; Zhou, L.; Martinez, E.; Von Roemeling, R. W.; Earhart, R. H.; McMahon, M.; Isufi, I.; Leslie, L. A. |
| Abstract Title: | Open-label, dose-escalation, and expansion trial of CA-4948 in combination with ibrutinib in patients with relapsed or refractory hematologic malignancies |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680302035 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.7575 |
| Notes: | Meeting Abstract: 7575 -- Meeting also held virtually -- Source: Wos |
